Where does MLEC stock trade?

Moolec Science SA (MLEC) is listed on NASDAQ.

What sector and industry is MLEC in?

Moolec Science SA operates in the Finance sector, Blank Checks industry.

What are analysts saying about MLEC?

Moolec Science SA has had 1 recent analyst action on file. The most recent action was from ROTH MKM: Buy with a $500.00 price target on 2023-09-27. Recent price targets cluster around $500.00.

What companies are similar to MLEC?

Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare MLEC side-by-side with any of them on Quantisnow.

How can I track MLEC on Quantisnow?

Quantisnow aggregates Moolec Science SA's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLEC to receive live email and push alerts on every new disclosure.

MLEC

NASDAQ

Moolec Science SA

SectorFinanceIndustryBlank Checks

$7.76-0.47 (-5.77%)

News25/Ratings1

Price$7.76-2.90 (-27.20%)

2026-03-042026-06-05

News · 26 weeks35-83%

2025-12-142026-06-07

Mix1990d

Insider9(47%)
SEC Filings6(32%)
Market4(21%)

Latest news

25 items

6dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
25dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
25dNEWS
Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States
WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the 2026 commercial planting campaign for its GLASO1 safflower program focused on the production of high-GLA ("Gamma-Linolenic Acid") specialty oils for industrial and advanced ingredient applications."Today represents a defining moment for Moolec. Regaining compliance with Nasdaq while simultaneously advancing the commercial execution of our GLASO1 platform reflect
25dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
25dNEWS
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period
GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / May 13, 2026 / As previously reported on January 29, 2026, Moolec Science SA ("Moolec" and/or the "Company"), received written notice from the Nasdaq Hearings Panel (the "Panel") informing the Company that the Panel had granted the Company's request for an extension to regain compliance with the continued listing requirements of The Nasdaq Stock Market LLC, specifically with respect to the minimum stockholders' equity requirement.The Company announced today that it has submitted information required to demonstrate compliance with the Nasdaq Capital Market's stockholders' equity requirement within the remediation period granted by the Panel. The
26dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
40dNEWS
Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications
WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the first phase of industrialization of its GLASO1 safflower platform, following a 2025 campaign that materially exceeded all internal forecasts.Building on previously reported results confirming approximately 45% GLA ("Gamma-linolenic acid") concentration at commercial scale, the Company has now validated not only agronomic and processing performance, but also th
54dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
54dINSIDER
SEC Form 3 filed by new insider Core Daniel Joaquin
3 - Moolec Science SA (0001937737) (Issuer)
62dNEWS
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds
WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced a significant scientific breakthrough in the production of animal proteins in plants.Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the common pea (Pisum sativum).Platform Expansion: A New Cr
67dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
81dINSIDER
SEC Form 3 filed by new insider Falottico Valeria Ines
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Varela Lorenzo Romualdo Mariano
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Diaz Dellavalle Paola Alexandra
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Diaz Dellavalle Paola Alexandra
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Abelleyra Llodra Diego Juan
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Antalich Raibar Alejandro Carlos
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Leon Bentancor Oscar Alejandro
3 - Moolec Science SA (0001937737) (Issuer)
81dINSIDER
SEC Form 3 filed by new insider Montaron Estrada Gloria
3 - Moolec Science SA (0001937737) (Issuer)
102dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
115dNEWS
Moolec Science Achieves One of the Highest Commercial-Scale GLA Concentrations From U.S. GLASO1 Crushing
WARWICK, UK / ACCESS Newswire / February 13, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC)("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced positive results from the crushing process of its U.S. GLASO1 safflower platform, confirming gamma-linolenic acid ("GLA") concentrations of approximately 45%.The results follow the successful completion of Moolec's 2025 U.S. GLASO1 safflower campaign and represent a major operational milestone, validating the Company's ability to deliver commercial-scale agricultural and industrial performa
129dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
129dNEWS
Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions
GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 30, 2026 / Moolec Science S.A. ("Moolec" or the "Company"), a science-based food ingredient company focused on scalable protein solutions for the global market, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions.The Panel acknowledged that the Company satisfied the minimum bid price compliance period under Nasdaq Listing Rule 5550(b)(2) on January 16, 2026, following the effectiveness of its reverse stock split on January 5, 2026. The Panel will retain jurisdiction over the bid price matter through May 13, 2026, in
135dSEC
SEC Form 6-K filed by Moolec Science SA
6-K - Moolec Science SA (0001937737) (Filer)
135dNEWS
Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement
GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 23, 2026 / Moolec Science S.A. ("Moolec" or the "Company") today announced that Nasdaq Staff has issued a memorandum to the Nasdaq Hearings Panel (the "Panel") concluding that there is sufficient basis to grant Moolec an exception through June 29, 2026 to demonstrate compliance with the stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), subject to certain disclosure conditions.The Staff memo reflects Nasdaq's acknowledgment of the material improvement in Moolec's balance sheet following a series of accounting and corporate events completed during the fourth quarter of 2

MLEC FAQ

5 questions

Where does MLEC stock trade?
Moolec Science SA (MLEC) is listed on NASDAQ.
What sector and industry is MLEC in?
Moolec Science SA operates in the Finance sector, Blank Checks industry.
What are analysts saying about MLEC?
Moolec Science SA has had 1 recent analyst action on file. The most recent action was from ROTH MKM: Buy with a $500.00 price target on 2023-09-27. Recent price targets cluster around $500.00.
What companies are similar to MLEC?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare MLEC side-by-side with any of them on Quantisnow.
How can I track MLEC on Quantisnow?
Quantisnow aggregates Moolec Science SA's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLEC to receive live email and push alerts on every new disclosure.